Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 857-862, February 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balakrishnan, A.
Right arrow Articles by Nandi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balakrishnan, A.
Right arrow Articles by Nandi, S.

Differential Proliferative Response to Linoleate in Cultures of Epithelial Cells from Normal Human Breast and Fibroadenomas1

Arun Balakrishnan2, Scott Cramer, Gautam K. Bandyopadhyay, Walter Imagawa, Jason Yang, Joel Elias, Craig W. Beattie, Tapas K. Das Gupta and Satyabrata Nandi

Cancer Research Laboratory, University of California, Berkeley, California 94720 [A. B., S. C., G. B., W. I., J. Y., S. N.], Department of Anatomy, University of California, San Francisco, California 94143 [J. E.], and Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, College of Medicine, Chicago, Illinois [C. B., T. D.]

Human breast epithelial cells isolated from normal breast tissues of premenopausal women demonstrated direct evidence of a proliferative effect by linoleate (18:2{omega}6) or prostaglandin E2 (PGE2) in the presence of insulin and epidermal growth factor in serum-free cultures within a collagen gel matrix. Neither epidermal growth factor nor 18:2{omega}6 by itself was capable of stimulating growth but together they stimulated proliferation synergistically. Epithelial cells isolated from fibroadenomas on the other hand failed to exhibit any growth stimulation due to 18:2{omega}6 or PGE2. The linoleate-stimulated growth in normal breast epithelial cells was inhibited by indomethacin, a cyclooxygenase inhibitor, which however could be reversed by PGE2.

The proliferative response of normal breast epithelial cells to 18:2{omega}6 was accompanied by a greater conversion of [14C]18:2{omega}6 to arachidonic acid and [14C]20:4{omega}6 to prostaglandins than that seen in epithelial cells from fibroadenomas. The turnover of [14C]18:2{omega}6 in the phospholipids of normal cells was higher than in fibroadenomas indicating a possible role of phospholipids in mediating the 18:2{omega}6 effect in normal cells.

Both normal and fibroadenoma cells can proliferate in response to cholera toxin and glucocorticoids when supplemented to the insulin- and epidermal growth factor-containing medium. From the results it appears that, unlike normal cells, fibroadenoma cells may have a specific defect in the PGE2-responsive cyclic AMP-generating mechanism whereas cholera toxin-induced mechanism is operative in both types of cells.

1 This work was supported in part by American Cancer Society Grant PDT 252, NIH Grant CA05388, NIH Grant CA40160, and NIH Grant CA09041.

2 To whom requests for reprints should be addressed, at Cancer Research Laboratory, 3510 Life Sciences Building, University of California, Berkeley, CA 94720.

Received 3/28/88. Revised 8/23/88. Revised 11/ 7/88. Accepted 11/10/88.




This article has been cited by other articles:


Home page
J. Nutr.Home page
L. D. Yee, D. C. Young, T. J. Rosol, A. M. VanBuskirk, and S. K. Clinton
Dietary (n-3) Polyunsaturated Fatty Acids Inhibit HER-2/neu-Induced Breast Cancer in Mice Independently of the PPAR{gamma} Ligand Rosiglitazone
J. Nutr., May 1, 2005; 135(5): 983 - 988.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Natarajan, R. Esworthy, W. Bai, J.-L. Gu, S. Wilczynski, and J. Nadler
Increased 12-Lipoxygenase Expression in Breast Cancer Tissues and Cells. Regulation by Epidermal Growth Factor
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1790 - 1798.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.